Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations

v3.19.2
Consolidated Statements of Operations - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Operating expenses        
Research and development $ 4,804,076 $ 5,252,334 $ 8,911,216 $ 9,987,674
General and administrative 2,603,403 2,244,120 4,857,996 4,492,949
Total operating expenses 7,407,479 7,496,454 13,769,212 14,480,623
Loss from operations (7,407,479) (7,496,454) (13,769,212) (14,480,623)
Other income (expense):        
Interest income 104,441 163,145 253,560 315,392
Change in fair value of warrant liabilities (1,363,868) (12,802,583) 16,435,761 (25,077,142)
Total other income (expense) (1,259,427) (12,639,438) 16,689,321 (24,761,750)
Net income (loss) $ (8,666,906) $ (20,135,892) $ 2,920,109 $ (39,242,373)
Basic net income (loss) per share $ (0.11) $ (0.27) $ 0.04 $ (0.53)
Shares used in computing basic net income (loss) per share 79,409,556 73,658,529 79,409,556 73,657,537
Diluted net income (loss) per share $ (0.11) $ (0.27) $ 0.04 $ (0.53)
Shares used in computing diluted net income (loss) per share 79,406,556 73,658,529 79,457,926 73,657,537